DIRS.INFO The most relevant business & tech news

☆ 'Top quality asset': Strategist names his top stock to buy in India right now
▼ + stars: | 2024-11-19 | by ( Amala Balakrishner | In Amala-Balakrishner | ) www.cnbc.com time to read: +2 min

Indian markets have been under pressure in recent weeks, but strategist Matt Orton remains bullish on the country, revealing "one of his favorite" stocks right now. ICIC Bank One stock that stands out to Orton is private bank and financial services player ICICI Bank . "ICICI Bank is one of my favorite picks because it's just a top-quality asset. ICICIBANK-IN YTD mountain Year-to-date shares in ICICI Bank Orton said ICICI is among the three "domestic systemically important banks," or those considered " too big to fail " banks by the Reserve Bank of India. According to FactSet data, of 44 analysts covering the stock, 41 give it a buy or overweight rating, while the remaining three have a hold call.

Persons: Matt Orton, Raymond James, CNBC's, Orton, it's, ICICI Bank Orton, Jefferies Organizations: Raymond James Investment Management, Bombay Stock Exchange, ICICI Bank, India's, Bombay Stock Exchanges, ICICI, Reserve Bank of India Locations: bullish, India, U.S, Mumbai

☆ Look for investment themes with bipartisan support under Trump's second term: Strategist
▼ + stars: | 2024-11-18 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailLook for investment themes with bipartisan support under Trump's second term: StrategistMatt Orton of Raymond James Investment Management discusses the sectors that could benefit from the bipartisan support for infrastructure investment and expected fiscal measures.

Persons: Matt Orton, Raymond James Organizations: Raymond James Investment Management

☆ Orton: I see no reason why we can't get post 6000
▼ + stars: | 2024-10-14 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailOrton: I see no reason why we can't get post 6000Matt Orton, CFA, Chief Market Strategist at Raymond James Investment Management, discusses the upcoming earnings season and emphasizes the concept of "dispersion," where not all companies will perform equally.

Persons: Matt Orton Organizations: CFA, Chief, Raymond James Investment Management

☆ Will see a 'gradual cutting pace' from the Federal Reserve, strategist says
▼ + stars: | 2024-09-19 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailWill see a 'gradual cutting pace' from the Federal Reserve, strategist saysMatt Orton, chief market strategist at Raymond James Investment Management, discusses the impact of the Federal Reserve's latest interest rate decision and the outlook for monetary policy.

Persons: Matt Orton Organizations: Federal Reserve, Raymond James Investment Management

☆ Market is 'getting ahead of itself' by pricing in aggressive cuts, says Raymond James' Orton
▼ + stars: | 2024-08-23 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailMarket is 'getting ahead of itself' by pricing in aggressive cuts, says Raymond James' OrtonMatt Orton, chief market strategist at Raymond James Investment Management, joins CNBC's 'The Exchange' to discuss why he's not seeing weakness in the labor market, why this means the market may not be pricing in rate cuts correctly, and more.

Persons: Raymond James, Orton Matt Orton Organizations: Raymond James Investment Management

☆ No conclusive evidence that the U.S. is 'rapidly slipping' into a recession: Strategist
▼ + stars: | 2024-08-02 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailNo conclusive evidence that the U.S. is 'rapidly slipping' into a recession: StrategistMatt Orton, chief market strategist at Raymond James Investment Management, discusses the Wall Street selloff and says it's not something investors should be concerned about.

Persons: Matt Orton, it's Organizations: Raymond James Investment Management

☆ Stick with momentum winners in this market, says Raymond James' Matt Orton
▼ + stars: | 2024-06-27 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailStick with momentum winners in this market, says Raymond James' Matt OrtonMatt Orton, chief market strategist at Raymond James Investment Management, joins 'The Exchange' to discuss why he believes in sticking with mega-cap stocks, a bullish case on big banks, and more.

Persons: Raymond James, Matt Orton Matt Orton Organizations: Raymond James Investment Management

☆ Earnings remain 'key catalyst' that will keep bull market going, says Raymond James' Matt Orton
▼ + stars: | 2024-04-24 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailEarnings remain 'key catalyst' that will keep bull market going, says Raymond James' Matt OrtonMatt Orton, chief market strategist at Raymond James Investment Management, joins CNBC's 'The Exchange' to discuss what he's paying attention to this earnings season, small cap winners, and more.

Persons: Raymond James, Matt Orton Matt Orton Organizations: Raymond James Investment Management

☆ 'A fantastic market': Strategist names one under-the-radar stock to play in Japan right now
▼ + stars: | 2024-04-03 | by ( Amala Balakrishner | In Amala-Balakrishner | ) www.cnbc.com time to read: +1 min

Several investors have been looking favorably at Japanese stocks in the past few months, and market strategist Matt Orton is no exception. "Japan overall, has been a fantastic market ... Japan was the top performer within the Asian equity market complex," the chief market strategist at asset management firm Raymond James Investment Management told CNBC's " Squawk Box Asia " on April 1. One stock that stands out to Orton is Sumitomo Mitsui Financial Group . Of the 14 analysts covering the stock, 10 give it a buy or overweight rating, while four have a hold rating, according to FactSet data. Analysts' average price target for the stock is 9,537.50 Japanese yen ($62.89), giving it around 11% potential upside.

Persons: Matt Orton, Raymond James, CNBC's, levered, they've, Orton Organizations: Raymond James Investment Management, Japan's Nikkei, Tokyo Exchange, Orton, Sumitomo Mitsui Financial Group, Sumitomo Locations: Japan, Tokyo, Indonesia, India, Vietnam, Philippines

☆ 'Very, very attractive': Strategist names 2 under-the-radar U.S. small-cap names to play right now
▼ + stars: | 2024-04-02 | by ( Amala Balakrishner | In Amala-Balakrishner | ) www.cnbc.com time to read: +3 min

Market strategist Matt Orton sees promise in small-cap stocks this year, naming four under-the-radar companies he is bullish on right now. Year-to-date, the Russell 2000 , the benchmark for small-cap stocks, has been up nearly 5.2% despite having a tough start to 2024. Small-cap players in the U.S. stand out as "very, very attractive" right now, he said, naming Vertiv Holdings and CyberArk as two companies on his radar. The market strategist remains confident on the stock, noting that "just because it is up, doesn't mean you don't want to own it." CyberArk The market strategist also has his eye on the cybersecurity space.

Persons: Matt Orton, Orton, Raymond James, CNBC's, Russell Organizations: Raymond James Investment Management, Vertiv Holdings, Vertiv Holdings Vertiv Holdings Locations: 2H24, U.S

☆ 'We're back to a stock picker's market,' Raymond James says
▼ + stars: | 2024-03-18 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via Email'We're back to a stock picker's market,' Raymond James saysMatt Orton, chief market strategist at Raymond James Investment Management, says the market has stabilised such that "the fundamentals matter again" and investors can be rewarded for individual stock selection.

Persons: Raymond James, Matt Orton Organizations: Raymond James Investment Management

☆ 'Find growth': Strategist tells investors not to worry about high stock valuations
▼ + stars: | 2024-03-18 | by ( Elliot Smith | ) www.cnbc.com time to read: +1 min

Investors should disregard concerns over high valuations and focus on growth in what is now a "stockpicker's market," according to Matt Orton, chief market strategist at Raymond James Investment Management. The S&P 500 closed out a two-week losing streak on Friday, but Orton told CNBC that stock market gains are broadening and brief pullbacks should be used "opportunistically." Much of the significant rally over the last 18 months has been driven by the so-called "Magnificent 7" megacap tech stocks, but they have begun to diverge. "We're back to a stockpicker's market – idiosyncratic risk is finally being rewarded again and that, to me, is most important. It means that you have the opportunity to diversify your portfolio and actually lean into what works and lean out of what's not," Orton told CNBC's "Squawk Box Europe" on Monday.

Persons: Matt Orton, Orton, Tesla, CNBC's Organizations: Raymond James Investment Management, CNBC, Apple, Microsoft, Nvidia

☆ The Fed probably won’t cut rates in March. Here’s what that means for markets
▼ + stars: | 2024-02-11 | by ( Krystal Hur | ) edition.cnn.com time to read: +6 min

Investors now expect that the Fed will begin easing back rates in May or June, according to the CME FedWatch Tool. Before the Bell: What does the Fed’s signal that it won’t cut rates in March mean for markets? I think what’s important for the markets themselves is the fact that the Fed has signaled they’re going to cut rates. So, they’re going to cut rates at some point this year, probably May or June is going to be the first cut that we get. There’s a lot of areas where your earnings … start to reaccelerate higher, and that’s a good thing.

Persons: Stocks, Jerome Powell, Bell, Matt Orton, I’ve, We’re, it’s, Matt Egan, Read, Price Organizations: CNN Business, Bell, New York CNN, Investors, Fed, Raymond James Investment Management, The Conference, Conference, Avis Budget Group, Hasbro, Cola, Molson Coors, The, Labor Statistics, Kraft, Heinz, The Commerce Department, National Association of Home Builders, University of Michigan Locations: New York, Wells Fargo

☆ The S&P 500 is no longer a good barometer for the average stock, strategist says
▼ + stars: | 2024-02-09 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailThe S&P 500 is no longer a good barometer for the average stock, strategist saysMatt Orton, chief market strategist at Raymond James Investment Management, discusses the investment outlook and explains why he believes the S&P 500 is no longer a good barometer for the average stock.

Persons: Matt Orton Organizations: Raymond James Investment Management

☆ 'A trove of rebound opportunities': Strategists turn bullish on biotech and more, picking top stocks
▼ + stars: | 2024-01-17 | by ( Weizhen Tan | ) www.cnbc.com time to read: +4 min

2023 wasn't a good year for the health-care sector, but some investors expect it to make a comeback this year — highlighting biotech and medical tech as areas to watch. But now, Citi believes that "astute investors may find themselves with a trove of rebound opportunities." Citi's top picks in biotech include Biomea Fusion , Alnylam Pharmaceuticals , and Immunovant . Jared Holz, health-care sector strategist at Mizuho Securities Americas, named biotech firm Biogen as one of his top trading ideas for 2024. "Biotech has commanded everyone's attention, but the recovery of many best-in-class medical device companies post the GLP-1 selloff has been remarkable," Orton said.

Persons: There's, Jared Holz, Biogen, Trent, medtech, Matt Orton, Orton Organizations: Citi Global Wealth Investments, U.S . Healthcare, Citi, Biomea, Alnylam Pharmaceuticals, Mizuho Securities Americas, Biogen, medtech, Raymond James Investment Management, Medical, Biotech, Abbott Laboratories Locations: U.S, Alphinity, medtech

☆ Japan is the one place investors can be rewarded for leaning into value stocks: Raymond James IM
▼ + stars: | 2023-11-08 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailJapan is the one place investors can be rewarded for leaning into value stocks: Raymond James IMMatt Orton of Raymond James Investment Management says investors "have not missed the rally" in Japanese equities, explaining that there is value to be found in financial and industrial conglomerates.

Persons: Raymond James, Matt Orton Organizations: Japan, Raymond James Investment Management

☆ 'Incredibly compelling': The pros love small-cap stocks right now. Here are their top picks
▼ + stars: | 2023-09-21 | by ( Weizhen Tan | ) www.cnbc.com time to read: +4 min

Matt Orton, chief market strategist at Raymond James Investment Management, was the latest to urge investors to "strategically add" to small-cap stocks right now. Tom Ognar, senior portfolio manager at Allspring Global Investments, said small- and mid-cap stocks look the "most incrementally interesting" among growth stocks. "We're very attuned to the valuation discounts currently being afforded to small- and mid-cap stocks after protracted periods of underperformance relative to large-cap stocks," he said. It screened for the best small-cap stocks to play an economic recovery. RBC Capital Markets also released, in a September note, an updated list of what it called "high conviction" U.S. small-cap growth recommendations.

Persons: Matt Orton, Russell, CNBC's, Orton, Tom Ognar, Ognar, CNBC'S, Valvoline, it's, — CNBC's Michael Bloom Organizations: Raymond James Investment Management, Allspring Global Investments, . Bank of America, Microsystems, Technologies, RBC Capital Markets, Automotive, RBC, Clearwater Analytics, Clearwater, Xenon Pharmaceuticals

☆ Strategist says this tech giant is the 'cheapest of all the mega-cap names' right now
▼ + stars: | 2023-09-20 | by ( Weizhen Tan | ) www.cnbc.com time to read: +2 min

Tech giant Alphabet is "the cheapest" of all the mega-cap names, according to Matt Orton, chief market strategist at Raymond James Investment Management. With the U.S. consumer "holding up well," its ad-driven revenues are "incredibly strong," he told CNBC's " Street Signs Asia " on Monday. "That's probably the cheapest by far — the cheapest of all the mega-cap names, and so I think there's a lot of durability to Alphabet," he concluded. Orton said what's "most exciting" about Alphabet is the long-term artificial intelligence opportunity, adding that the tech giant is underappreciated in that regard. Alphabet versus Microsoft Alphabet and Microsoft will be the two long-term winners in AI, according to Orton.

Persons: Matt Orton, CNBC's, Orton, That's, what's Organizations: Raymond James Investment Management, Google, Microsoft Locations: Office360

☆ Alphabet has better AI product than anything else on the market: Strategist
▼ + stars: | 2023-09-18 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailAlphabet has better AI product than anything else on the market: StrategistMatt Orton of Raymond James Investment Management explains why Alphabet is his top pick when it comes to investing in AI.

Persons: Matt Orton, Raymond James Organizations: Raymond James Investment Management

March 20 (Reuters) - Shares of First Republic Bank (FRC.N) closed 47% lower on Monday, adding to recent losses as concerns about its liquidity continued to worry investors despite a $30 billion influx of deposits last week. The bank's stock fell as much as 50% and closed at $12.18 after the New York Stock Exchange halted it several times due to volatility. S&P Global downgraded First Republic deeper into junk status on Sunday and said the recent cash infusion from 11 large U.S. banks last week may not solve its liquidity problems. A First Republic Bank branch is pictured in Midtown Manhattan in New York City, New York, U.S., March 13, 2023. First Republic Bank's stock market collapseFirst Republic's stock market value has collapsed by over 80% in the past 10 trading sessions due to fears of a bank run as a large proportion of the lender's deposits are uninsured.

March 20 (Reuters) - Shares of First Republic Bank (FRC.N) extended a recent slump on Monday with a 15% drop, after a report the regional bank could raise more money fanned worries about its liquidity despite a $30 billion rescue last week. On Sunday, Reuters reported that the lender was still trying to put together a capital raise but that no deal was imminent. Short sellers in First Republic made about $560 million profit on paper since last Monday, analytics firm Ortex said. The S&P 1500 regional banks index (.SPCOMBNKS) added nearly 3.4%, while S&P 500 banks (.SPXBK) gained 2.3%. A U.S. official told Reuters on Sunday that the deposit outflows that left many regional banks reeling in the wake of Silicon Valley Bank's failure had slowed and in some cases reversed.

☆ Orton: The higher duration, lower parts of the market still have room to come down
▼ + stars: | 2023-02-21 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailOrton: The higher duration, lower parts of the market still have room to come downRaymond James Investment Management's Matt Orton gives his thoughts on the markets and the Fed.

ORLANDO, Fla., Feb 16 (Reuters) - The notion that higher interest rates would slam stocks has been turned on its head by Wall Street's resilience to the most dramatic upward repricing of the U.S. rate outlook in decades. More remarkable still, it is the areas most sensitive to higher borrowing costs - tech, the Nasdaq and growth stocks - that are outperforming in the face of soaring bond yields, implied rates and Fed expectations. These sectors are more sensitive to rising yields because future cash flows and profits are discounted at higher rates. "Higher interest rates are less bad for stock prices, even though rates can continue to weigh on multiples." In a higher rate regime, profitability matters.

☆ Orton: The market has been preoccupied with a Fed pivot, but the terminal rate hasn't changed
▼ + stars: | 2022-11-17 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailOrton: The market has been preoccupied with a Fed pivot, but the terminal rate hasn't changedMatt Orton of Raymond James Investment Management discusses what a potential downshift from the Fed to a 50 basis point hike really means, and where investors should target for opportunities right now.

Search resuls for: "Raymond James Investment Management"

24 mentions found